Updated November PresentationThe November presentation is out and the one thing I was looking for was if there were any changes to upcoming milestones. There were none that I notice.
NCC deal still H2 2020
Bioavailability study for Avenanthramide pill is also still H2 2020
They also added one slide for PGX-YBG, but no info besides picture of press release.